Skip to content

Marma Chikitsa In Lumbar Spondylosis

A Comparative Study On The Efficacy Of Marma Chikitsa And Physiotherapy In The Pain Management Of Lumbar Spondylosis - RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092177
Enrollment
40
Registered
2025-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M498- Spondylopathy in diseases classified elsewhere

Interventions

None listed

Sponsors

Pt khushilal Sharma Govt (Auto) Ayurveda College And Institute Bhopal Madhya Pradesh 462003
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex between 30 to 60 years of age 2.Duration of illness up to 2 years 3.Patients willing to sign the consent for participation in study

Exclusion criteria

Exclusion criteria: 1.Subject having Spinal tumor, Tuberculosis, Malignant disease of the pelvis, fracture of spine, Congenital or acquired skeletal deformity. 2.Any traumatic condition of spine. 3.Recent lumbar surgery or implanted instrumentation or prosthesis. 4.Pregnant and lactating women. 5.Having Chronic pathologies e.g. ankylosing spondylosis, rheumatoid arthritis, psoriatic arthritis, gouty arthritis or any other systemic illness.

Design outcomes

Primary

MeasureTime frame
It is expected that at the end of study, scholar will be able to evaluate the effect of Marma Chikitsa in the pain management of Lumbar Spondylosis (Katigraha).Timepoint: 15 Days

Secondary

MeasureTime frame
Marma Chikitsa Is Non Pharmaceutical Approach To Treat Lumbar Spondylosis (Katigraha)Timepoint: 15 Days

Countries

India

Contacts

Public ContactDr Mohini Rajoriya

Pt Khushilal Sharma Govt (Auto) Ayurveda College And Institute Bhopal Madhya Pradesh

nmandalik10@gmail.com9424542272

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026